| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-39406-0_9 |
| P698 | PubMed publication ID | 27558823 |
| P50 | author | Bernhard Brüne | Q84836238 |
| Divya Sekar | Q114979937 | ||
| Shahzad N Syed | Q41644029 | ||
| Andreas Weigert | Q48297787 | ||
| Javier Mora | Q51551699 | ||
| P2860 | cites work | Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells | Q21245767 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF | Q24329023 | ||
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications | Q24605052 | ||
| Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
| The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors | Q24631515 | ||
| Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions | Q26827662 | ||
| Macrophages in intestinal homeostasis and inflammation | Q26851960 | ||
| Macrophages: gatekeepers of tissue integrity | Q27007092 | ||
| Sensing of cell death by myeloid C-type lectin receptors | Q27010313 | ||
| Old, new and emerging functions of caspases | Q27686885 | ||
| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Cancer-related inflammation | Q27860907 | ||
| Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
| IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses | Q28303437 | ||
| Orchestration of metabolism by macrophages | Q38000642 | ||
| Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. | Q38003021 | ||
| Recruitment of monocytes/macrophages in different tumor microenvironments | Q38071483 | ||
| Tumor-associated macrophages: functional diversity, clinical significance, and open questions | Q38105286 | ||
| Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
| Origin and functions of tissue macrophages. | Q38230878 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| Homeostasis in the mononuclear phagocyte system | Q38232291 | ||
| Sinister self-sacrifice: the contribution of apoptosis to malignancy | Q38234939 | ||
| Macrophage iron homeostasis and polarization in the context of cancer | Q38254678 | ||
| Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. | Q38327926 | ||
| Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages | Q38939381 | ||
| Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy | Q38954212 | ||
| In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors | Q38998613 | ||
| Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo | Q39000247 | ||
| Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation | Q39000553 | ||
| Enhancement of anticancer effect of interferon-γ gene transfer against interferon-γ-resistant tumor by depletion of tumor-associated macrophages. | Q39007021 | ||
| 5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cells | Q39096052 | ||
| MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene | Q39129449 | ||
| miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis | Q39133794 | ||
| The resolution of inflammation | Q61053463 | ||
| Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages | Q61864573 | ||
| Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages | Q79287661 | ||
| Requirements for apoptotic cell contact in regulation of macrophage responses | Q80209354 | ||
| Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production | Q80210979 | ||
| Expression of Tie-2 by human monocytes and their responses to angiopoietin-2 | Q80358599 | ||
| Apoptotic cells quench reactive oxygen and nitrogen species and modulate TNF-alpha/TGF-beta1 balance in activated macrophages: involvement of phosphatidylserine-dependent and -independent pathways | Q81699209 | ||
| Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155 | Q84620188 | ||
| Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines | Q37185721 | ||
| A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. | Q37418671 | ||
| Microenvironmental influences of apoptosis in vivo and in vitro | Q37711148 | ||
| Mycobacterium bovis bacillus Calmette-Guérin-induced macrophage cytotoxicity against bladder cancer cells | Q37791443 | ||
| Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues | Q37815130 | ||
| Histone deacetylases as regulators of inflammation and immunity | Q37875468 | ||
| Tumor promotion via injury- and death-induced inflammation | Q37950602 | ||
| Cancer-related inflammation: common themes and therapeutic opportunities | Q37972525 | ||
| Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
| A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells | Q28476155 | ||
| miR-511-3p modulates genetic programs of tumor-associated macrophages | Q28504706 | ||
| 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance | Q28510985 | ||
| Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells | Q28540086 | ||
| Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression | Q28748638 | ||
| Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| The two NF-kappaB activation pathways and their role in innate and adaptive immunity | Q29614355 | ||
| Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
| Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
| Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 | ||
| Immunogenic cell death in cancer therapy | Q29620118 | ||
| A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
| Macrophage biology in development, homeostasis and disease | Q29620350 | ||
| Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin | Q30485290 | ||
| S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. | Q30514214 | ||
| M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway | Q30544968 | ||
| Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts | Q31137466 | ||
| Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages | Q33570011 | ||
| Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes | Q33731729 | ||
| Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813. | Q33976776 | ||
| Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways | Q34035175 | ||
| Tissue-specific signals control reversible program of localization and functional polarization of macrophages | Q34065482 | ||
| Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. | Q34142942 | ||
| Human dermal CD14⁺ cells are a transient population of monocyte-derived macrophages | Q34244161 | ||
| Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis | Q34248596 | ||
| CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. | Q34279134 | ||
| Tumor associated macrophages and neutrophils in tumor progression | Q34306107 | ||
| Immunogenic cell death and DAMPs in cancer therapy | Q34311701 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Environment drives selection and function of enhancers controlling tissue-specific macrophage identities | Q34452301 | ||
| Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation | Q39174587 | ||
| Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages | Q39225975 | ||
| Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate | Q39405948 | ||
| Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages | Q39409408 | ||
| Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy | Q39436858 | ||
| Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. | Q39568139 | ||
| The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). | Q39628899 | ||
| Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype | Q39823174 | ||
| CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis | Q39938633 | ||
| Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. | Q40102693 | ||
| Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft | Q40140782 | ||
| Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. | Q40280838 | ||
| Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. | Q40478439 | ||
| Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition | Q40602126 | ||
| Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. | Q40971597 | ||
| Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression | Q41750524 | ||
| Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. | Q42142782 | ||
| Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver | Q42223027 | ||
| The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal | Q42744709 | ||
| Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. | Q42828937 | ||
| RNAi screen in apoptotic cancer cell-stimulated human macrophages reveals co-regulation of IL-6/IL-10 expression | Q43593210 | ||
| A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. | Q43787598 | ||
| Phosphatidylserine peroxidation/externalization during staurosporine-induced apoptosis in HL-60 cells | Q44075460 | ||
| Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration | Q44125780 | ||
| The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages | Q45720263 | ||
| The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. | Q45956195 | ||
| Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences | Q46516651 | ||
| Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy | Q46817579 | ||
| Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression | Q46820182 | ||
| Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. | Q46845199 | ||
| Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. | Q48425484 | ||
| Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. | Q48509512 | ||
| Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity. | Q51830426 | ||
| Genetic Studies of the Relationship of Tumour–Host Cells: Effect of Tumour Cells killed by X-rays upon the Growth of Admixed Viable Cells | Q56656024 | ||
| Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages | Q56798121 | ||
| Role of Macrophage Targeting in the Antitumor Activity of Trabectedin | Q56942258 | ||
| p50 Nuclear Factor- B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance | Q56942931 | ||
| The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection | Q57062755 | ||
| Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells | Q57279527 | ||
| Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas | Q58212133 | ||
| A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). | Q34465280 | ||
| Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity | Q34625640 | ||
| Macrophage regulation of tumor responses to anticancer therapies | Q34649588 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff | Q34787221 | ||
| Targeting tumor-associated macrophages as a novel strategy against breast cancer | Q34803221 | ||
| CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages. | Q34990965 | ||
| Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival | Q34991697 | ||
| CSF-1R inhibition alters macrophage polarization and blocks glioma progression | Q34993852 | ||
| MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta | Q35011103 | ||
| Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy | Q35093740 | ||
| Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution | Q35140121 | ||
| CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth | Q35205613 | ||
| Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation | Q35276306 | ||
| Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells | Q35615917 | ||
| Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. | Q35623089 | ||
| Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states | Q35689569 | ||
| Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer | Q35871752 | ||
| Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide | Q35886752 | ||
| Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo | Q36053108 | ||
| TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. | Q36088939 | ||
| Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration | Q36191881 | ||
| The origin and kinetics of mononuclear phagocytes | Q36269269 | ||
| Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome | Q36310475 | ||
| Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages | Q36342694 | ||
| MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages | Q36357815 | ||
| Recognition ligands on apoptotic cells: a perspective | Q36461127 | ||
| Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses | Q36586333 | ||
| "Re-educating" tumor-associated macrophages by targeting NF-kappaB. | Q36699735 | ||
| Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal | Q36804936 | ||
| Trophic macrophages in development and disease | Q36829147 | ||
| Redox control of inflammation in macrophages | Q37032282 | ||
| Macrophage polarization in tumour progression | Q37158140 | ||
| Nitric oxide, apoptosis and macrophage polarization during tumor progression. | Q37166559 | ||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 35 | |
| P304 | page(s) | 205-239 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression. | |
| P478 | volume | 930 |
| Q52429963 | An apoptosis-driven 'onco-regenerative niche': roles of tumour-associated macrophages and extracellular vesicles. |
| Q64117034 | Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype |
| Q89342869 | Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin |
| Q41902511 | Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2? |
| Q92333454 | Role of tumor-associated immune cells in prostate cancer: angel or devil? |
| Q38626918 | S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1β or Lipocalin-2. |
| Q91981643 | Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity |
Search more.